U of A SBRP Homepage


NAV - image map, top of page navigation tool University of Arizona College of Pharmacy Center for Toxicology NIEHS U of A SBRP Homepage

Role of Annexin II in Peripheral Vascular Disease


Background
Chronic exposure to arsenic frequently results in peripheral vasular disease, as well as skin, lung, bladder, and kidney cancer. Recent evidence demonstrates that arsenite inhibits the production of plasmin which is necessary to dissolve blood clots in the vasulature. Our published studies with arsenic have demonstrated that the serine/threonin kinase, MEKK4, is involved in arsenic signal transduction, along with the calcium binding protein, annexin II.


Figure: Shows two proposed mechanisms for regulation of plasmin.
Figure shows two proposed mechanisms for regulation of plasmin.

Goal
To understand the molecular mechanism by which arsenic causes its deleterious effects on the vascular system and how the activity of annexin II contributes to arsenic toxicity.


Objectives
1. To characterize arsenic-dependent post-translational modifications of annexin II.

2. To characterize the interaction between annexin II and MEKK4.

3. To characterize arsenic-dependent regulation of PAI-1 and PAI-2.

4.To assess specific functions of annexin II.


Contact
Richard R. Vaillancourt
vaillancourt@pharmacy.arizona.edu
(520) 626-4374

 


Southwest Hazardous Waste Program
University of Arizona, College of Pharmacy, Room 136
PO Box 210207, Tucson, AZ, USA  85721-0207
superfund-info@pharmacy.arizona.edu
520-626-7101
520-626-2466(FAX)



Funded by
NIEHS grant # ES04940

© 1996-2006, The University of Arizona
Last update:  April 11, 2006
Page Content: Mónica Ramírez
Web Master: Mike Kopplin
Our Program News & Highlights Research Projects & Facilities Outreach to Mexico Graduate Trainees Personnel Useful Links Questions & Feedback Key Contacts Search College of Agriculture & Life Science College of Engineering College of Medicine College of Science